Cargando…
Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies
Cystic fibrosis (CF) is a genetic disease that affects the exocrine glands and is caused by cystic fibrosis transmembrane conductance regulator gene (CFTR) mutations. Lung disease is the leading cause of morbidity in patients. Target-specific treatment of CF has been achieved using monoclonal antibo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805982/ https://www.ncbi.nlm.nih.gov/pubmed/36601503 http://dx.doi.org/10.1016/j.jsps.2022.10.002 |